Abstract:Wound healing can lead to hypertrophic scar or keloid formation, characterized by an overabundant extracellular matrix. Current established treatment strategies include surgical resection, triamcinolone steroid injection, pressure therapy, silicone therapy, radiotherapy, etc. Cytokines also play a critical role in the regulation of cellular activities and extracellular matrix metabolism. Interferons (IFN) represent a group of antifibroproliferative agents that inhibit fibroblast proliferation and collagen production, and interleukin (IL)-1β also accelerates hypertrophic scar fibroblasts to produce collagenolytic enzymes, leading to tissue destruction. This study addressed the effects of steroid, IFN α-2b, or IL-1β on apoptosis and cell pathway of fibroblasts from keloids, hypertrophic scars, and normal skins and different responses of different fibroblasts. Six samples of keloid, six samples of hypertrophic scar, and six samples of normal skin were, respectively, collected from patients, and fibroblasts from different sources were cultured in vitro. After different fibroblasts were treated with dexamethasone (0.1 mg/ml) or IFN α-2b (1,000 μ/ml) or IL-1β (200 μ/ml), Bax and Bcl-2 were detected in situ by immunohistochemical staining; deoxyribonucleic acid ladders of different fibroblasts were observed by gel electrophoresis, and relative activated (phospho-) extracellular-signal-regulated kinase (ERK) 1/2 and c-Jun N-terminal kinase (JNK) pathways were detected by the method of fast activated cell-based enzyme-linked immunosorbent assay. In media containing dexamethasone, apoptosis took place in fibroblasts from keloids, hypertrophic scars, and normal skins by gel electrophoresis with increased rate of Bax/Bcl-2. Activated (phospho-) ERK1/2 and activated (phospho-) JNK expressions increased in three different fibroblasts. In media containing IFN α-2b, no apoptosis took place in three different fibroblasts without any change of expressions of Bax and Bcl-2 except for the expression of decreased Bcl-2 in fibroblasts from keloids. Activated (phospho-) ERK1/2 expression decreased in fibroblasts from keloid and hypertrophic scars without any changes of activated (phospho-) JNK expression, and IFN α-2b did not affect both activated (phospho-) ERK1/2 and activated (phospho-) JNK expressions in fibroblasts from normal skin. In media containing IL-1β, apoptosis of fibroblasts from keloids was induced by stimulating activated (phospho-) ERK1/2 and activated (phospho-) JNK pathways; IL-1β could not induce apoptosis of fibroblasts from normal skin (radio of Bax/Bcl-2 decreasing) whose activated (phospho-) ERK1/2 pathway was stimulated without any changes of activated (phospho-) JNK expression. Apoptosis in fibroblasts from hypertrophic scars was induced by activating the JNK pathway and prohibiting the ERK1/2 pathway. The effects of steroid, IFN α-2b, or IL-1β on apoptosis of different fibroblasts were different through different cell signal pathways, although all of them were effective for treatment of abnormal scars.

Severe Hypoxia and Malnutrition Collectively Contribute to Scar Fibroblast Inhibition and Cell Apoptosis

Decreased Expression of Microrna-145 Promotes the Biological Functions of Fibroblasts in Hypertrophic Scar Tissues by Upregulating the Expression of Transcription Factor SOX-9

[Effects of Severe Hypoxia and Low Concentration of Serum Protein on the Function of Human Hypertrophic Scar Fibroblasts].

Hypertrophic Scar Regression is Linked to the Occurrence of Endothelial Dysfunction.

Transition of autophagy and apoptosis in fibroblasts depends on dominant expression of HIF-1 alpha or p53

Hyperactivity of fibroblasts and functional regression of endothelial cells contribute to microvessel occlusion in hypertrophic scarring.

Hypoxia-inducible Factor-1Α Activates Transforming Growth Factor-Β1/smad Signaling and Increases Collagen Deposition in Dermal Fibroblasts

Fibroblasts and endothelial cells interplay drives hypertrophic scar formation: Insights from in vitro and in vivo models

Dynamic Hypoxia in Scar Tissue During Human Hypertrophic Scar Progression.

Adipose-Derived Mesenchymal Stem Cells Alleviate Hypertrophic Scar by Inhibiting Bioactivity and Inducing Apoptosis in Hypertrophic Scar Fibroblasts

The regulatory role of the apelin/APJ axis in scarring: Identification of upstream and downstream mechanisms

Hypoxia Drives the Transition of Human Dermal Fibroblasts to a Myofibroblast-Like Phenotype Via the TGF-β1/Smad3 Pathway

Effects of Different Hypoxia on Proliferation of Dermal Scar Fibroblasts

Effects of Steroids, Interferon-2B, or Interluekin 1B on Apoptosis of Fibroblasts from Keloid, Hypertrophic Scars, and Normal Skin and Related Signal Pathway

SHH induces macrophage oxidative phosphorylation and efferocytosis to promote scar formation

Dynamic Biological Changes In Fibroblasts During Hypertrophic Scar Formation And Regression

[The Expression of HIF-1alpha in Scars and Its Relationship to Apoptosis].

Effects of hypoxia on the expression of hypoxia inducible factor 1 alpha in scar fibroblasts

Study on the Biological Function of Vascular Endothelial Cells in the Hypertrophic Scar

Altered glucose metabolism and cell function in keloid fibroblasts under hypoxia

Inhibition of Pathological Phenotype of Hypertrophic Scar Fibroblasts Via Coculture with Adipose-Derived Stem Cells.